Found 36 matching trials
Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases PHASE2 This phase II trial investigates how well a naive T cell depleted graft wor...
Show More Location
Seattle Children's Hospital
Learn More & Join Trial
Two Step Haplo With Radiation Conditioning PHASE2 This phase II clinical trial evaluates whether a modified modality of condi...
Show More Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Learn More & Join Trial
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia PHASE3 RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, an...
Show More Location
HealthOne Presbyterian St. Lukes Medical Center
Learn More & Join Trial
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML PHASE2 This is a multicenter, open-label study in people aged 18 and older with re...
Show More Location
Multiple Locations
Learn More & Join Trial
Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies PHASE2 This study will determine the safety and applicability of experimental form...
Show More Location
Cancer Institute of New Jersey
Learn More & Join Trial
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs PHASE2 This is a single-institution, phase II study to determine the event-free su...
Show More Location
University of Minnesota Masonic Cancer Center and Medical Center
Learn More & Join Trial
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders PHASE1 This study is designed to estimate the efficacy and toxicity of familial HL...
Show More Location
Yale School of Medicine
Learn More & Join Trial
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome PHASE2 Background:
Allogeneic hematopoietic stem cell transplant involves taking ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers PHASE2 Background:
Some blood cancers can be caused by germline variants (changes...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Allo HSCT for High Risk Hemoglobinopathies PHASE2 A single center, open label, interventional, phase II trial for donor trans...
Show More Location
Masonic Cancer Center
Learn More & Join Trial